Cat. No.: 5101ERFX
Enrofloxacin (1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6 fluoro-1,
4- dihydro-4-oxo-3-quinolone carboxylic acid) is a synthetic 6-fluoroquinolone which acts by inhibiting bacterial DNA-gyrase. In veterinary medicine it is administered through a subcutaneous injection to cattle, intra-muscularly for pigs, and orally for cattle, pigs, turkeys and chickens. In Europe, the European Commission, Council Regulation No. 2377/90 and its successive regulations has established the Maximum Residue Limits (MRLs) for drugs employed in veterinary medicine. The MRLs for the sum of enrofloxacin and its active metabolite ciprofloxacin have been stated at 100 µg/kg for muscle tissue and fat (bovine, ovine, caprine, porcine, rabbits, poultry), 200 µg/kg for kidney and 300 µg/kg for liver (bovine, ovine, caprine), 300 µg/kg for kidney and 200 µg/kg for liver (porcine, rabbits, poultry), and 100 µg/kg for milk (bovine, ovine, caprine). The antibody used in the ELISA test is specific for enrofloxacin and does not cross-react with any of the other fluoroquinolones tested. Detailed information of this product is given in the Product Information Sheet.
|Product information sheet ERFX15||Download|